# An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection

> **NCT02045251** · PHASE4 · WITHDRAWN · sponsor: **American University of Beirut Medical Center**

## Conditions studied

- Treatment of H. Pylori Infection

## Interventions

- **DRUG:** Pylera based reduced regimen

## Key facts

- **NCT ID:** NCT02045251
- **Lead sponsor:** American University of Beirut Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-06
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unavailability of clarithromycin 250 mg in the market
- **Last updated:** 2015-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02045251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02045251, "An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02045251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*